At Binghamton University, researchers were among the first to find ways to help patients with Duchenne muscular dystrophy (DMD) through the development of an effective drug. Now, they are continuing that work, looking to reduce its effects even earlier.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗